Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seroquel Safety Study

NCT01342120 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01342120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01342120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seroquel Safety Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 30, 2010
Completion date
November 30, 2010
Enrollment
18,325 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, generalized anxiety disorder, major depressive disorder, schizophrenia